Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12726
PUT
AdvisorShares Pure Cannabis ETF
YOLO
$32.2M
| $19.3K | ﹤0.01% |
5,900
+1,100
| +23% | +$3.66K |
2022 Q4
7 quarters
|
|
12727
PUT
ProShares UltraShort Russell2000
TWM
$64.9M
| $19.2K | ﹤0.01% |
+420
| New | +$21.1K |
2024 Q3
0 quarters
|
|
12728
CALL
Cohen & Steers
CNS
$3.74B
| $19.2K | ﹤0.01% |
200
+100
| +100% | +$8.51K |
2022 Q4
7 quarters
|
|
|
BRKL
12729
CALL
DELISTED
Brookline Bancorp
BRKL
| $19.2K | ﹤0.01% |
1,900
+1,600
| +533% | +$15.7K |
2023 Q1
6 quarters
|
|
|
LAR
12730
Lithium Argentina AG
LAR
$917M
| $19.1K | ﹤0.01% |
5,862
-6,090
| -51% | -$16.9K |
2023 Q4
3 quarters
|
|
12731
Indaptus Therapeutics
INDP
$341M
| $19.1K | ﹤0.01% |
550
-243
| -31% | -$11.9K |
2024 Q2
1 quarter
|
|
|
BCIC
12732
BCP Investment Corp
BCIC
$86.1M
| $19.1K | ﹤0.01% |
1,028
-20,001
| -95% | -$380K |
2022 Q2
9 quarters
|
|
|
ENG
12733
DELISTED
ENGlobal Corp
ENG
| $19.1K | ﹤0.01% |
+15,008
| New | +$22.2K |
2024 Q3
0 quarters
|
|
12734
Pulmonx
LUNG
$76.9M
| $19.1K | ﹤0.01% |
2,299
-147,911
| -98% | -$1.07M |
2020 Q4
15 quarters
|
|
12735
PUT
Viemed Healthcare
VMD
$357M
| $19.1K | ﹤0.01% |
2,600
-1,100
| -30% | -$7.86K |
2024 Q2
1 quarter
|
|
12736
PUT
Hillman Solutions
HLMN
$1.38B
| $19K | ﹤0.01% |
1,800
-800
| -31% | -$7.72K |
2022 Q4
7 quarters
|
|
|
IMMP
12737
CALL
Immutep
IMMP
$32.1M
| $19K | ﹤0.01% |
430
+385
| +856% | +$17K |
2022 Q4
7 quarters
|
|
|
NXTS
12738
Nexentis Technologies
NXTS
$2.01M
| $19K | ﹤0.01% |
310
+221
| +248% | +$20.6K |
2024 Q2
1 quarter
|
|
12739
PUT
Vanguard FTSE All-World ex-US ETF
VEU
$69.3B
| $18.9K | ﹤0.01% |
300
| – | – |
2024 Q2
1 quarter
|
|
12740
CALL
iShares 25+ Year Treasury STRIPS Bond ETF
GOVZ
$314M
| $18.9K | ﹤0.01% |
400
-375
| -48% | -$17.4K |
2024 Q1
2 quarters
|
|
12741
PUT
Outdoor Holding Co
POWW
$253M
| $18.9K | ﹤0.01% |
13,200
-3,700
| -22% | -$5.86K |
2021 Q1
14 quarters
|
|
12742
PUT
Vinci Compass Investments Ltd
VINP
$708M
| $18.9K | ﹤0.01% |
1,900
-2,600
| -58% | -$27.7K |
2023 Q1
6 quarters
|
|
|
SPCK
12743
CALL
The SPAC and New Issue ETF
SPCK
$8.09M
| $18.9K | ﹤0.01% |
800
+700
| +700% | +$16.5K |
2023 Q3
4 quarters
|
|
12744
CALL
Amplify Seymour Cannabis ETF
CNBS
$70.4M
| $18.9K | ﹤0.01% |
+350
| New | +$18.7K |
2024 Q3
0 quarters
|
|
12745
PUT
Amalgamated Financial
AMAL
$1.43B
| $18.8K | ﹤0.01% |
+600
| New | +$18.2K |
2024 Q3
0 quarters
|
|
12746
CALL
Mirion Technologies
MIR
$3.9B
| $18.8K | ﹤0.01% |
1,700
-1,000
| -37% | -$10.5K |
2021 Q1
14 quarters
|
|
|
CRDL
12747
PUT
Cardiol Therapeutics
CRDL
$157M
| $18.8K | ﹤0.01% |
9,500
+2,100
| +28% | +$4.36K |
2024 Q2
1 quarter
|
|
12748
CALL
iShares US Infrastructure ETF
IFRA
$4.05B
| $18.8K | ﹤0.01% |
400
-10,800
| -96% | -$482K |
2024 Q1
2 quarters
|
|
|
LUCK
12749
CALL
Lucky Strike Entertainment
LUCK
$720M
| $18.8K | ﹤0.01% |
1,600
-14,100
| -90% | -$171K |
2022 Q3
8 quarters
|
|
|
NREF
12750
PUT
NexPoint Real Estate Finance
NREF
$293M
| $18.8K | ﹤0.01% |
+1,200
| New | +$18K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.